Comparison of the Tolerability of Two Formulations of Hypertonic Saline in Cystic Fibrosis Patients

NCT01658449 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

OTHER: Inhalable Hypertonic saline 7% + Hyaluronan 0.1%
OTHER: Inhalable Hypertonic saline 7%

Sponsor

Ospedale Civile Ca' Foncello